Full-Year Adjusted EBITDA Growth
Adjusted EBITDA for fiscal 2025 increased 6% year-over-year to $199.0 million (EBITDA up 11% to $208.0 million), driven by disciplined pricing, cost management, favorable mix, and growth across strategic businesses.
Positive Free Cash Flow and Improved Leverage
Generated positive free cash flow of $25.4 million (Q4 free cash flow $25.4 million vs. negative $0.2 million prior-year Q4); cash from operations for the year was $148 million. Net debt decreased to $494 million (a $32 million reduction year-over-year) and net leverage improved from 2.8x to ~2.5x.
Organic Volume and Segment Volume Wins
Global organic sales volume grew 2% for the full year. Polymers delivered strong volume growth (Q4 volume +11%; Polymers net sales $132 million vs $113 million prior year, approximately +16.8%) and Polymers adjusted EBITDA increased ~9% in Q4.
Commissioning and Ramp of Pasadena Facility
Successfully commissioned the Pasadena alkoxylation facility; production ramp underway with management expecting ~70%-80% utilization in 2026 and full utilization in 2027, supporting footprint optimization and future growth.
Project Catalyst: Large Cost-Savings Program Announced
Launched Project Catalyst targeting approximately $100 million in pretax savings over the next two years, with ~60% (~$60 million) expected in 2026. Program focuses on footprint optimization, operational efficiency, and organizational effectiveness.
Dividend Increase and Shareholder Returns
Declared quarterly cash dividend of $0.395 per share payable 03/13/2026 (a 2.6% increase vs prior year). Company increased its dividend for the 58th consecutive year and paid $8.9 million in dividends in 2025.
Best Safety Performance
Delivered the best year on safety results in company history, a notable operational achievement and risk-reduction indicator.
Selective Growth in Strategic End Markets
Strong growth in crop productivity, oilfield (tier two/three customers), global Polymers, and Specialty Products (including double-digit volume growth in medium chain triglycerides), with mid-single-digit growth in tier two/three customer segment.